The company estimates that about six million people annually in the United States, primarily children, are affected by the condition which previously had no approved treatments.
Tag Archive for: Verrica Pharmaceuticals
Verrica Pharmaceuticals has received the company’s third Complete Response Letter (CRL) from the U.S. Food and Drug Administration for its New Drug Application for the molluscum contagiosum treatment candidate VP-102.
